GlassScriptPhysician profile
Deanna L Aftab Guy
NPI 1760579890
$11,156.22
in general payments reported to CMS, 2019-2025
30 companies · $4,197 in 2025
The $4,197 reported for 2025 was more than what 82% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,185 · 2020: $1,819 · 2021: $521 · 2022: $256 · 2023: $371 · 2024: $2,808 · 2025: $4,197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,600 · Travel and Lodging: $2,253 · Food and Beverage: $1,480 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,600.00 |
| Travel and Lodging | $2,253.42 |
| Food and Beverage | $1,479.69 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $6,386.34 | 2019-2025 | |
| Abbvie INC. | $2,281.62 | 2019-2024 | Lupron Depot |
| Novo Nordisk INC | $813.66 | 2019-2025 | Sogroya, Norditropin, Ozempic |
| Insulet Corporation | $352.79 | 2019-2025 | Omnipod |
| Arbor Pharmaceuticals, INC. | $156.87 | 2019 | |
| Beta Bionics, INC. | $145.99 | 2024 | Ilet Bionic Pancreas |
| Tolmar, INC. | $136.15 | 2025 | Fensolvi |
| Ferring Pharmaceuticals INC. | $104.90 | 2019-2020 | |
| Medtronic, INC. | $94.88 | 2021-2024 | Minimed 780g |
| Neurocrine Biosciences, INC. | $81.28 | 2024-2025 | |
| Companion Medical, INC. | $79.32 | 2019-2020 | |
| Csl Behring | $63.28 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $53.23 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Xeris Pharmaceuticals, INC. | $46.67 | 2021 | |
| Mannkind Corporation | $42.50 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $37.20 | 2019 | |
| Medtronic Minimed, INC. | $31.91 | 2019 | |
| Sandoz INC. | $29.15 | 2023 | Omnitrope |
| Amgen INC. | $27.01 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $24.09 | 2023 | Imcivree |
| Kyowa Kirin, INC. | $23.18 | 2023 | |
| Y-Mabs Therapeutics, INC. | $21.91 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.25 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.85 | 2023 | |
| Lifescan, INC. | $15.32 | 2022 | |
| Biomarin Pharmaceutical INC. | $15.32 | 2022 | |
| Senseonics, Incorporated | $15.00 | 2020 | |
| Amneal Pharmaceuticals LLC | $14.87 | 2021 | |
| Ascendis Pharma Endocrinology INC | $13.98 | 2024 | |
| Abbott Laboratories | $11.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanna Aftab Guy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.